Trial data comparison: difference between revisions
Diff·revision 26 → 27·07:44, 17 Apr 2025
Difference between revision 26 and revision 27 of Trial data comparison. 7 lines changed; the page grew by 157 bytes.
| Revision 26 — 17:46, 8 Apr 2025 RfC_Rasmus (talk) rm unsourced claim per PP:V 3,866 bytes +649 | Revision 27 — 07:44, 17 Apr 2025 Chromatokid (talk) split section 4,023 bytes +157 | ||
|---|---|---|---|
| 39 | <ref name="surpass2">Frías JP, Davies MJ, Rosenstock J, et al. "Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes." ''New England Journal of Medicine'' 385(6):503–515 (2021). DOI:10.1056/NEJMoa2107519. PMID 34170647.</ref> | 39 | <ref name="surpass2">Frías JP, Davies MJ, Rosenstock J, et al. "Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes." ''New England Journal of Medicine'' 385(6):503–515 (2021). DOI:10.1056/NEJMoa2107519. PMID 34170647.</ref> |
| 40 | 40 | ||
| + | 41 | == See also == | |
| + | 42 | * [[STEP trial programme]] | |
| + | 43 | * [[SURMOUNT trial programme]] | |
| + | 44 | * [[SURPASS trial programme]] | |
| + | 45 | * [[SELECT trial]] | |
| + | 46 | * [[Intention-to-treat analysis]] | |
| + | 47 | ||
| 41 | {{DEFAULTSORT:Trial data comparison}} | 48 | {{DEFAULTSORT:Trial data comparison}} |
| 42 | [[Category:Interactive reference tools]] | 49 | [[Category:Interactive reference tools]] |